We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

66 hedge funds and large institutions have $449M invested in Taro Pharmaceutical Industries Ltd. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

20% more funds holding

Funds holding: 55 → 66 (+11)

10% more capital invested

Capital invested by funds: $408M → $449M (+$41M)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
66
Holders Change
+11
Holders Change %
+20%
% of All Funds
1.91%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.17%
New
19
Increased
22
Reduced
17
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
Raging Capital Management
New Jersey
+$7.56M
2
Morgan Stanley
Morgan Stanley
New York
+$6.11M
3
PA
Perceptive Advisors
New York
+$4.4M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.26M
5
Renaissance Technologies
Renaissance Technologies
New York
+$3.58M

Top Sellers

1
AIM
Assured Investment Management
New York
-$21.6M
2
GCM
Greywolf Capital Management
New York
-$20.7M
3
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management
California
-$8.13M
4
PCM
PAR Capital Management
Massachusetts
-$3.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
ICM
1
ISZO Capital Management
New York
$123M +$120M +1,104,208 New
AIM
2
Assured Investment Management
New York
$53.1M -$21.6M -198,283 -29%
Hotchkis & Wiley Capital Management
3
Hotchkis & Wiley Capital Management
California
$50.5M -$8.13M -74,684 -14%
GCM
4
Greywolf Capital Management
New York
$31.3M -$20.7M -190,448 -40%
CCM
5
Consonance Capital Management
New York
$30.6M +$1.25M +11,500 +4%
Renaissance Technologies
6
Renaissance Technologies
New York
$29.8M +$3.58M +32,927 +14%
RCM
7
Raging Capital Management
New Jersey
$28.8M +$7.56M +69,463 +37%
VCAM
8
Valentine Capital Asset Management
California
$16.7M +$597K +5,482 +4%
KCM
9
Kennedy Capital Management
Missouri
$11.1M +$255K +2,343 +2%
PA
10
Perceptive Advisors
New York
$10.8M +$4.4M +40,409 +71%
MCP
11
Moab Capital Partners
New York
$10.4M +$1.12M +10,301 +12%
Morgan Stanley
12
Morgan Stanley
New York
$8.51M +$6.11M +56,086 +273%
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$4.46M +$2.46M +22,600 +125%
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$4.34M +$4.26M +39,100 New
Canada Pension Plan Investment Board
15
Canada Pension Plan Investment Board
Ontario, Canada
$3.86M – – –
Fiera Capital (Canada)
16
Fiera Capital (Canada)
Quebec, Canada
$2.9M +$2.84M +26,100 New
ACM
17
Ativo Capital Management
Illinois
$2.54M +$6.86K +63 +0.3%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$2.07M +$1.55M +14,217 +322%
Barclays
19
Barclays
United Kingdom
$1.75M +$1.42M +13,069 +479%
AL
20
AJO LP
Pennsylvania
$1.75M +$1.72M +15,800 New
JHIU
21
Janus Henderson Investors US
Colorado
$1.7M +$521K +4,788 +45%
U
22
UBS
Switzerland
$1.66M -$402K -3,697 -20%
PNC Financial Services Group
23
PNC Financial Services Group
Pennsylvania
$1.28M -$66.3K -609 -5%
BIT
24
BlackRock Institutional Trust
California
$1.23M -$141K -1,295 -10%
NA
25
Navellier & Associates
Nevada
$1.13M -$845K -7,761 -43%
1
2 3

TARO Hedge Fund Activity: Q1 2014 in Review

66 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q1 2014, worth a combined $449M — up 10% from $408M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new TARO positions and 7 closed out — a net gain of 12 holders — while 22 added to existing stakes and 17 trimmed.

The largest buyer was Raging Capital Management, adding an estimated $7.56M. The largest seller was Assured Investment Management, cutting an estimated $21.6M.

  • 66 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q1 2014, up from 55 in Q4 2013.
  • Funds reported $449M of Taro Pharmaceutical Industries Ltd. stock for Q1 2014, up 10% quarter-over-quarter.
  • 19 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q1 2014 and 7 closed out, a net change of +12 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q1 2014 was Raging Capital Management, an estimated $7.56M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q1 2014 was Assured Investment Management, an estimated $21.6M sold.

Based on aggregated 13F filings for Q1 2014.